Oruka Therapeutics to Present at Multiple March Investor Conferences
Oruka Therapeutics (Nasdaq: ORKA), a clinical stage biotechnology company focused on developing novel biologics for chronic skin diseases including plaque psoriasis, has announced its participation in two major investor conferences in March 2025.
The company will present at TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4th, 2025, at 10:30 AM ET, and at the Leerink Global Healthcare Conference on Wednesday, March 12th, 2025, at 8:40 AM ET.
Investors can access the webcasts and replays of these presentations through Oruka's investor events website at https://ir.orukatx.com/news-events/events-presentations.
Oruka Therapeutics (Nasdaq: ORKA), una società biotecnologica in fase clinica focalizzata sullo sviluppo di nuovi biologici per malattie croniche della pelle, tra cui la psoriasi a placche, ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo 2025.
La società presenterà alla 45ª Conferenza Annuale sulla Salute di TD Cowen martedì 4 marzo 2025, alle 10:30 AM ET, e alla Conferenza Globale sulla Salute di Leerink mercoledì 12 marzo 2025, alle 8:40 AM ET.
Gli investitori possono accedere ai webcast e alle registrazioni di queste presentazioni attraverso il sito web degli eventi per investitori di Oruka all'indirizzo https://ir.orukatx.com/news-events/events-presentations.
Oruka Therapeutics (Nasdaq: ORKA), una compañía biofarmacéutica en etapa clínica enfocada en el desarrollo de nuevos biológicos para enfermedades crónicas de la piel, incluyendo la psoriasis en placas, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025.
La compañía presentará en la 45ª Conferencia Anual de Salud de TD Cowen el martes 4 de marzo de 2025, a las 10:30 AM ET, y en la Conferencia Global de Salud de Leerink el miércoles 12 de marzo de 2025, a las 8:40 AM ET.
Los inversores pueden acceder a las transmisiones web y repeticiones de estas presentaciones a través del sitio web de eventos para inversores de Oruka en https://ir.orukatx.com/news-events/events-presentations.
Oruka Therapeutics (Nasdaq: ORKA)는 판상 건선 등 만성 피부 질환을 위한 새로운 생물학적 제제를 개발하는 데 중점을 둔 임상 단계의 생명공학 회사로, 2025년 3월 두 개의 주요 투자자 회의에 참여한다고 발표했습니다.
회사는 2025년 3월 4일 화요일 오전 10시 30분 ET에 TD Cowen 제45회 연례 건강 관리 회의에서 발표하고, 2025년 3월 12일 수요일 오전 8시 40분 ET에 Leerink 글로벌 건강 관리 회의에서 발표할 예정입니다.
투자자들은 Oruka의 투자자 이벤트 웹사이트 https://ir.orukatx.com/news-events/events-presentations를 통해 이러한 발표의 웹캐스트 및 재생을 이용할 수 있습니다.
Oruka Therapeutics (Nasdaq: ORKA), une entreprise de biotechnologie en phase clinique axée sur le développement de nouveaux biologiques pour les maladies chroniques de la peau, y compris le psoriasis en plaques, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025.
L'entreprise présentera à la 45e Conférence Annuelle sur la Santé de TD Cowen le mardi 4 mars 2025 à 10h30 ET, et à la Conférence Mondiale sur la Santé de Leerink le mercredi 12 mars 2025 à 8h40 ET.
Les investisseurs peuvent accéder aux webcasts et aux rediffusions de ces présentations via le site web des événements pour investisseurs d'Oruka à l'adresse https://ir.orukatx.com/news-events/events-presentations.
Oruka Therapeutics (Nasdaq: ORKA), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung neuer biologischer Wirkstoffe für chronische Hautkrankheiten, einschließlich Plaque-Psoriasis, konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt.
Das Unternehmen wird am Dienstag, den 4. März 2025, um 10:30 Uhr ET auf der 45. jährlichen Gesundheitskonferenz von TD Cowen und am Mittwoch, den 12. März 2025, um 8:40 Uhr ET auf der Leerink Global Healthcare Conference präsentieren.
Investoren können die Webcasts und Wiederholungen dieser Präsentationen über die Investorenevents-Website von Oruka unter https://ir.orukatx.com/news-events/events-presentations abrufen.
- None.
- None.
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences:
TD Cowen’s 45th Annual Health Care Conference
Date: Tuesday, March 4th, 2025
Time: 10:30AM ET
Leerink Global Healthcare Conference
Date: Wednesday, March 12th, 2025
Time: 8:40AM ET
A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at https://ir.orukatx.com/news-events/events-presentations.
About Oruka Therapeutics
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.
Investor Contact:
Alan Lada
(650)-606-7911
alan.lada@orukatx.com
FAQ
When is Oruka Therapeutics (ORKA) presenting at TD Cowen's Healthcare Conference in March 2025?
What time is Oruka Therapeutics (ORKA) presenting at the Leerink Global Healthcare Conference?
How can investors access Oruka Therapeutics' (ORKA) March 2025 conference presentations?
What therapeutic areas is Oruka Therapeutics (ORKA) focusing on in their development pipeline?
